Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer. (1st January 2020)
- Record Type:
- Journal Article
- Title:
- Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer. (1st January 2020)
- Main Title:
- Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer
- Authors:
- Hamy, Anne-Sophie
Derosa, Lisa
Valdelièvre, Constance
Yonekura, Satoru
Opolon, Paule
Priour, Maël
Guerin, Julien
Pierga, Jean-Yves
Asselain, Bernard
De Croze, Diane
Pinheiro, Alice
Lae, Marick
Talagrand, Laure-Sophie
Laas, Enora
Darrigues, Lauren
Grandal, Beatriz
Marangoni, Elisabetta
Montaudon, Elodie
Kroemer, Guido
Zitvogel, Laurence
Reyal, Fabien - Abstract:
- ABSTRACT: Immunosurveillance plays an important role in breast cancer (BC) prognosis and progression, and can be geared by immunogenic chemotherapy. In a cohort of 1023 BC patients treated with neoadjuvant chemotherapy (NAC), 40% of the individuals took comedications mostly linked to aging and comorbidities. We systematically analyzed the off-target effects of 1178 concurrent comedications (classified according to the Anatomical Therapeutic Chemical (ATC) Classification System) on the density of tumor-infiltrating lymphocytes (TILs) and pathological complete responses (pCR). At level 1 of the ATC system, the main anatomical classes of drugs were those targeting the nervous system (class N, 39.1%), cardiovascular disorders (class C, 26.6%), alimentary and metabolism (class A, 16.9%), or hormonal preparations (class H, 6.5%). At level 2, the most frequent therapeutic classes were psycholeptics (N05), analgesics (N02), and psychoanaleptics (N06). Pre-NAC TIL density in triple-negative BC (TNBC) was influenced by medications from class H, N, and A, while TIL density in HER2 + BC was associated with the use of class C. Psycholeptics (N05) and agents acting on the renin-angiotensin system (C09) were independently associated with pCR in the whole population of BC or TNBC, and in HER2 -positive BC, respectively. Importantly, level 3 hypnotics (N05C) alone were able to reduce tumor growth in BC bearing mice and increased the anti-cancer activity of cyclophosphamide in a TABSTRACT: Immunosurveillance plays an important role in breast cancer (BC) prognosis and progression, and can be geared by immunogenic chemotherapy. In a cohort of 1023 BC patients treated with neoadjuvant chemotherapy (NAC), 40% of the individuals took comedications mostly linked to aging and comorbidities. We systematically analyzed the off-target effects of 1178 concurrent comedications (classified according to the Anatomical Therapeutic Chemical (ATC) Classification System) on the density of tumor-infiltrating lymphocytes (TILs) and pathological complete responses (pCR). At level 1 of the ATC system, the main anatomical classes of drugs were those targeting the nervous system (class N, 39.1%), cardiovascular disorders (class C, 26.6%), alimentary and metabolism (class A, 16.9%), or hormonal preparations (class H, 6.5%). At level 2, the most frequent therapeutic classes were psycholeptics (N05), analgesics (N02), and psychoanaleptics (N06). Pre-NAC TIL density in triple-negative BC (TNBC) was influenced by medications from class H, N, and A, while TIL density in HER2 + BC was associated with the use of class C. Psycholeptics (N05) and agents acting on the renin-angiotensin system (C09) were independently associated with pCR in the whole population of BC or TNBC, and in HER2 -positive BC, respectively. Importantly, level 3 hypnotics (N05C) alone were able to reduce tumor growth in BC bearing mice and increased the anti-cancer activity of cyclophosphamide in a T cell-dependent manner. These findings prompt for further exploration of drugs interactions in cancer, and for prospective drug-repositioning strategies to improve the efficacy of NAC in BC. … (more)
- Is Part Of:
- Oncoimmunology. Volume 9:Number 1(2020)
- Journal:
- Oncoimmunology
- Issue:
- Volume 9:Number 1(2020)
- Issue Display:
- Volume 9, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 9
- Issue:
- 1
- Issue Sort Value:
- 2020-0009-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-01-01
- Subjects:
- Breast cancer -- immunomodulation -- comedication -- pCR -- TILs
Tumors -- Immunological aspects -- Periodicals
Neoplasms -- therapy -- Periodicals
Immunotherapy -- Periodicals
616.994 - Journal URLs:
- http://www.landesbioscience.com/journals/oncoimmunology/ ↗
http://www.tandfonline.com/toc/koni20/current ↗
http://www.tandf.co.uk/journals/ ↗ - DOI:
- 10.1080/2162402X.2019.1677427 ↗
- Languages:
- English
- ISSNs:
- 2162-402X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26300.xml